Related Experiment Videos
[Nonalcoholic steatohepatitis in children]
Sandra Cubelić1, Zrinjka Misak, Slavko Gasparov
1Referentni centar za djecju gastroenterologiju i prehranu, Klinika za djecje bolesti Zagreb, Zagreb.
Lijecnicki Vjesnik
|March 10, 2005
Summary
Pediatric nonalcoholic steatohepatitis (NASH) is diagnosed in obese children. Lifestyle changes, including diet and exercise, effectively reduced BMI and improved liver enzymes in young NASH patients.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Metabolic Disorders
Background:
- Nonalcoholic steatohepatitis (NASH) is increasingly recognized in children, mirroring adult prevalence.
- Diagnosis in pediatric populations involves elevated aminotransferases, characteristic imaging, and liver biopsy findings, excluding other causes of steatosis.
- Early diagnosis and intervention are crucial to prevent progressive liver damage and fibrosis in children.
Observation:
- The study presents five pediatric NASH cases (2 girls, 3 boys; ages 11-15 years).
- All participants were obese, presenting with elevated transaminases and imaging/biopsy findings consistent with NASH.
- Key diagnostic criteria included hepatocyte fat vacuoles, inflammation, and potential fibrosis on liver biopsy.
Findings:
- A low-calorie diet intervention led to decreased Body Mass Index (BMI) in all patients.
- Clinical symptoms of NASH resolved following dietary changes.
- Transaminase levels decreased significantly, with normalization observed in two patients.
Implications:
- Lifestyle modifications, specifically dietary changes, represent a primary therapeutic strategy for pediatric NASH.
- Effective management of pediatric NASH can mitigate long-term liver damage and associated comorbidities.
- Further research into adjuvant therapies like ursodeoxycholic acid and vitamin E in children is warranted.